S

Shionogi & Co Ltd
TSE:4507

Watchlist Manager
Shionogi & Co Ltd
TSE:4507
Watchlist
Price: 2 924.5 JPY 2.88% Market Closed
Market Cap: 2.6T JPY

Relative Value

The Relative Value of one Shionogi & Co Ltd stock under the Base Case scenario is hidden JPY. Compared to the current market price of 2 924.5 JPY, Shionogi & Co Ltd is hidden .

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

Shionogi & Co Ltd Relative Value
HIDDEN
Show
Worst Case
Base Case
Best Case

Valuation Multiples

vs History
0
vs Industry
27
Median 3Y
4.4
Median 5Y
2.1
Industry
2.6
Forward
4.9
vs History
0
vs Industry
36
Median 3Y
11.7
Median 5Y
5.8
Industry
21.4
Forward
12.7
vs History
9
vs Industry
39
Median 3Y
10
Median 5Y
5.9
Industry
16.4
vs History
19
vs Industry
27
Median 3Y
12.6
Median 5Y
9.2
Industry
22.8
vs History
0
vs Industry
49
Median 3Y
1.4
Median 5Y
0.7
Industry
2.2
vs History
0
vs Industry
35
Median 3Y
3.1
Median 5Y
0.7
Industry
2.9
Forward
3.8
vs History
0
vs Industry
51
Median 3Y
3.6
Median 5Y
0.9
Industry
5.5
vs History
0
vs Industry
36
Median 3Y
7.9
Median 5Y
1.9
Industry
13
Forward
9.7
vs History
0
vs Industry
38
Median 3Y
8.9
Median 5Y
2.1
Industry
16.5
Forward
0
vs History
7
vs Industry
45
Median 3Y
6.9
Median 5Y
1.9
Industry
15.6
vs History
14
vs Industry
33
Median 3Y
9.2
Median 5Y
2.8
Industry
18.7
vs History
0
vs Industry
43
Median 3Y
1.5
Median 5Y
0.4
Industry
1.9

Multiples Across Competitors

Competitors Multiples
Shionogi & Co Ltd Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
All Countries
Close
Market Cap P/S P/E EV/EBITDA EV/EBIT
JP
Shionogi & Co Ltd
TSE:4507
2.5T JPY 5.7 14.6 10.9 12.4
US
Eli Lilly and Co
NYSE:LLY
1T USD 17.3 55.7 37.4 40.1
UK
Dechra Pharmaceuticals PLC
LSE:DPH
440.4B GBP 578.3 -15 783.5 3 846.3 17 702.3
US
Johnson & Johnson
NYSE:JNJ
495.1B USD 5.4 19.7 16.1 20.9
CH
Roche Holding AG
SIX:ROG
270.3B CHF 4.4 28.7 12.2 14.2
UK
AstraZeneca PLC
LSE:AZN
219.8B GBP 5.1 31.4 108.8 159.2
US
Merck & Co Inc
NYSE:MRK
276.1B USD 4.3 14.5 10.3 12.2
CH
Novartis AG
SIX:NOVN
218.3B CHF 4.9 19 12 15.5
DK
Novo Nordisk A/S
CSE:NOVO B
1.6T DKK 5.2 15.8 11 12.8
IE
Endo International PLC
LSE:0Y5F
213.9B USD 92.2 -73.2 338.7 849.2
US
Pfizer Inc
NYSE:PFE
143.8B USD 2.3 14.6 7.5 10.2
P/E Multiple
Earnings Growth PEG
JP
S
Shionogi & Co Ltd
TSE:4507
Average P/E: 23.8
14.6
8%
1.8
US
Eli Lilly and Co
NYSE:LLY
55.7
54%
1
UK
Dechra Pharmaceuticals PLC
LSE:DPH
Negative Multiple: -15 783.5 N/A N/A
US
Johnson & Johnson
NYSE:JNJ
19.7
29%
0.7
CH
Roche Holding AG
SIX:ROG
28.7
29%
1
UK
AstraZeneca PLC
LSE:AZN
31.4
37%
0.8
US
Merck & Co Inc
NYSE:MRK
14.5
15%
1
CH
Novartis AG
SIX:NOVN
19
17%
1.1
DK
Novo Nordisk A/S
CSE:NOVO B
15.8
3%
5.3
IE
E
Endo International PLC
LSE:0Y5F
Negative Multiple: -73.2 N/A N/A
US
Pfizer Inc
NYSE:PFE
14.6
27%
0.5
EV/EBITDA Multiple
EBITDA Growth EV/EBITDA to Growth
JP
S
Shionogi & Co Ltd
TSE:4507
Average EV/EBITDA: 401
10.9
8%
1.4
US
Eli Lilly and Co
NYSE:LLY
37.4
34%
1.1
UK
Dechra Pharmaceuticals PLC
LSE:DPH
3 846.3
36%
106.8
US
Johnson & Johnson
NYSE:JNJ
16.1
9%
1.8
CH
Roche Holding AG
SIX:ROG
12.2
5%
2.4
UK
AstraZeneca PLC
LSE:AZN
108.8
10%
10.9
US
Merck & Co Inc
NYSE:MRK
10.3
6%
1.7
CH
Novartis AG
SIX:NOVN
12
6%
2
DK
Novo Nordisk A/S
CSE:NOVO B
11
1%
11
IE
E
Endo International PLC
LSE:0Y5F
338.7
N/A N/A
US
Pfizer Inc
NYSE:PFE
7.5
0%
N/A
EV/EBIT Multiple
EBIT Growth EV/EBIT to Growth
JP
S
Shionogi & Co Ltd
TSE:4507
Average EV/EBIT: 1 713.5
12.4
N/A N/A
US
Eli Lilly and Co
NYSE:LLY
40.1
36%
1.1
UK
Dechra Pharmaceuticals PLC
LSE:DPH
17 702.3
98%
180.6
US
Johnson & Johnson
NYSE:JNJ
20.9
15%
1.4
CH
Roche Holding AG
SIX:ROG
14.2
6%
2.4
UK
AstraZeneca PLC
LSE:AZN
159.2
23%
6.9
US
Merck & Co Inc
NYSE:MRK
12.2
8%
1.5
CH
Novartis AG
SIX:NOVN
15.5
12%
1.3
DK
Novo Nordisk A/S
CSE:NOVO B
12.8
0%
N/A
IE
E
Endo International PLC
LSE:0Y5F
849.2
N/A N/A
US
Pfizer Inc
NYSE:PFE
10.2
7%
1.5